133
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations

, , , &
Pages 2351-2366 | Published online: 14 Oct 2011

References

  • ZaruMMourtasSKlepetsanisPFaddaAMAntimisiarisSGLiposomes for drug delivery to the lungs by nebulizationEur J Pharm Biopharm200767365566617540552
  • JaspartSBertholetPPielGDogneJMDelattreLEvrardBSolid lipid microparticles as a sustained release system for pulmonary drug deliveryEur J Pharm Biopharm2007651475616962749
  • BaileyMMBerklandCJNanoparticle formulations in pulmonary drug deliveryMed Res Rev200929119621218958847
  • CookROPannuRKKellawayIWNovel sustained release microspheres for pulmonary drug deliveryJ Control Release20051041799015866336
  • FuJFiegelJKraulandEHanesJNew polymeric carriers for controlled drug delivery following inhalation or injectionBiomaterials200223224425443312219833
  • GrenhaAGraingerCIDaileyLAChitosan nanoparticles are compatible with respiratory epithelial cells in vitroEur J Pharm Sci2007312738417408932
  • SmolaMVandammeTSokolowskiANanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseasesInt J Nanomedicine20083111918488412
  • El-SherbinyIMSmythHDCBiodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheresInt J Pharm20103951–213214120580794
  • GrenhaASeijoBRemunan-LopezCMicroencapsulated chitosan nanoparticles for lung protein deliveryEur J Pharm Sci2005254–542743715893461
  • GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release20051091–316918816289422
  • MikhailASAllenCBlock copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levelsJ Control Release2009138321422319376167
  • RiessGMicellization of block copolymersProg Polym Sci200328711071170
  • GaoZLukyanovANSinghalATorchilinVPDiacyllipid-Polymer Micelles as Nanocarriers for Poorly Soluble Anticancer DrugsNano Lett200229979982
  • TorchilinVPStructure and design of polymeric surfactant-based drug delivery systemsJ Control Release2001732–313717211516494
  • JonesMCLerouxJCPolymeric micelles – a new generation of colloidal drug carriersEur J Pharm Biopharm199948210111110469928
  • SezginZYükselNBaykaraTPreparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugsEur J Pharm Biopharm200664326126816884896
  • LimSBRubinsteinIÖnyükselHFreeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicellesInt J Pharm20083561–234535018289811
  • SmolaMVandammeTSokolowskiANanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseasesInt J Nanomedicine20083111918488412
  • VermehrenCJørgensenKSchiffelersRFrokjaerSActivity of mammalian secreted phospholipase A(2) from inflammatory peritoneal fluid towards PEG-liposomes. Early indicationsInt J Pharm20012141–2939811282244
  • KooOMRubinsteinIOnyukselHCamptothecin in sterically stabilized phospholipid micelles: a novel nanomedicineNanomedicine200511778417292061
  • CesurHRubinsteinIPaiAÖnyükselHSelf-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancerNanomedicine20095217818319071064
  • ZhangLHuYJiangXYangCLuWYangYHCamptothecin derivative- loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in miceJ Control Release200496113514815063036
  • SahibMNDarwisYKhiangPKTanYTFAerodynamic characterization of marketed inhaler dosage forms: High performance liquid chromatography assay method for the determination of budesonideAfr J Pharm Pharmacol2010412878884
  • DaviesNMFeddahMRA novel method for assessing dissolution of aerosol inhaler productsInt J Pharm20032551–217518712672613
  • ZhangYHuoMZhouJDDSolver: an add-in program for modeling and comparison of drug dissolution profilesAAPS J201012326327120373062
  • CostaFOSousaJJPaisAAFormosinhoSJComparison of dissolution profiles of ibuprofen pelletsJ Control Release200389219921212711444
  • SahibMNDarwisYKhiangPKFung TanYTAerodynamic characterization of beclomethasone dipropionate from beclate-50 inhaler® by HPLC-UVJ Liq Chromatogr Relat Technol2011348613621
  • WigginsNAThe Development of a Mathematical Approximation Technique to Determine the Mass Median Aerodynamic Diameter (MMAD) and Geometric Standard Deviation (GSD) of Drug Particles in an Inhalation Aerosol SpratDrug Dev Ind Pharm1991171419711986
  • YamamotoHKunoYSugimotoSTakeuchiHKawashimaYSurface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsJ Control Release2005102237338115653158
  • OnoueSSatoHKawabataYMizumotoTHashimotoNYamadaSIn vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapyJ Control Release20091381162319376169
  • GreenCKnightJPreciousSSimpkinSKetamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experienceLab Anim19811521631707278122
  • AnderssonSEZackrissonCBehrensKEffect of allergen provocation on inflammatory cell profile and endothelin-like immunoreactivity in guinea-pig airwaysAllergy19955043493587573819
  • SakagamiMKinoshitaWSakonKSatoJMakinoYMucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluationJ Control Release2002801–320721811943399
  • ZhangJXHansenCBAllenTMBoeyABochRLipid-derivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivativesJ Control Release2003862–332333812526828
  • RijckenCJSogaOHenninkWENostrumCFTriggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug deliveryJ Control Release2007120313114817582642
  • YangWPetersJIWilliamsROIIIInhaled nanoparticles – a current reviewInt J Pharm20083561–223924718358652
  • GillKKNazzalSKaddoumiAPaclitaxel loaded PEG5000-DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluationEur J Pharm Biopharm57201179227628421575719
  • FidlerIJRazAFoglerWEKirshRBugelskiPPosteGDesign of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophagesCancer Res19804012446044667002293
  • ZhangJXLiXJQiuLYIndomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluationJ Control Release2006116332232917109985
  • AliabadiHMElhasiSMahmudAGulamhuseinRMahdipoorPLavasanifarAEncapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: The effect of solvent composition on micellar properties and drug loadingInt J Pharm20073291–215816517008034
  • MuLFengSSFabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiersJ Control Release200176323925411578739
  • AriasMJMoyanoJRGinésJMStudy by DSC and HSM of the oxazepam-PEG 6000 and oxazepam-D-mannitol systems: Application to the preparation of solid dispersionsThermochim Acta19983211–23341
  • ZhangXJacksonJKBurtHMDevelopment of amphiphilic diblock copolymers as micellar carriers of taxolInt J Pharm19961321–2195206
  • AliHREdwardsHGKendrickJMunshiTScowenIJVibrational spectroscopic study of budesonideJ Raman Spectrosc2007387903908
  • TajberLCorriganDOCorriganOIHealyAMSpray drying of budesonide, formoterol fumarate and their composites – I. Physicochemical characterisationInt J Pharm20093671–2798518929631
  • FalamarzianALavasanifarAOptimization of the hydrophobic domain in poly(ethylene oxide)-poly([var epsilon]-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin BColloids Surf B Biointerfaces201081131332020674292
  • MuthuMSinghSPoly (D, L-Lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in-vitro evaluationCurr Drug Deliv200961626819418957
  • CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
  • DashSMurthyPNNathLChowdhuryPKinetic modeling on drug release from controlled drug delivery systemsActa Pol Pharm201067321722320524422
  • DerakhshandehKSoheiliMDadashzadehSSaghiriRPreparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patientsInt J Nanomedicine2010546347120957168
  • AbdullaJMTanYTDarwisYRehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulizationAAPS Pharm Sci Tech2010112663671
  • FieldAPDiscovering statistics using SPSS: (and sex and drugs and rock ‘n’ roll)3London, UKSAGE publications Ltd2009
  • YukselNKanikAEBaykaraTComparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methodsInt J Pharm20002091–2576711084246
  • ChowSCKiFYStatistical comparison between dissolution profiles of drug productsJ Biopharm Stat1997722412589136067
  • PolliJERekhiGSAugsburgerLLShahVPMethods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tabletsJ Pharm Sci19978666907009188051
  • GonjariIDKarmarkarABHosmaniAEvaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tabletsDigest J Nanomaterials Biostructures20094651661
  • AdamsECoomansDSmeyers-VerbekeJMassartDLApplication of linear mixed effects models to the evaluation of dissolution profilesInt J Pharm20012261–210712511532575
  • O’HaraTDunneAButlerJDevaneJA review of methods used to compare dissolution profile dataPharm Sci and Technolo Today199815214223
  • VaghiABergELiljedahlSSvenssonJOIn vitro comparison of nebulised budesonide (Pulmicort Respules®) and beclomethasone dipropionate (Clenil® per Aerosol)Pulm Pharmacol Ther200518215115315649857
  • OstranderKDBoschHWBondanzaDMAn in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulizationEur J Pharm Biopharm199948320721510612031
  • DaileyLASchmehlTGesslerTNebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol featuresJ Control Release200386113114412490379
  • CoombesAGTaskerSLindbladMBiodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segmentsBiomaterials19971817115311619259512
  • MitchellJNewmanSChanHKIn vitro and in vivo aspects of cascade impactor tests and inhaler performance: a reviewAAPS Pharm Sci Tech200784E110
  • DawkinsPAStockleyRAAnimal models of chronic obstructive pulmonary diseaseThorax2001561297297711713362
  • LeungSYWilliamsASNathPDose-dependent inhibition of allergic inflammation and bronchial hyperresponsiveness by budesonide in ovalbumin-sensitised Brown-Norway ratsPulm Pharmacol Ther20082119810417331766
  • Miller-LarssonAJanssonPRunstromABrattsandRProlonged airway activity and improved selectivity of budesonide possibly due to esterificationAm J Respir Crit Care Med20001624 Pt 11455146111029361
  • TrondeANordénBMarchnerHWendelAKLennernäsHBengtssonUHPulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugsJ Pharm Sci20039261216123312761811
  • TrondeANordénBJeppssonABDrug absorption from the isolated perfused rat lung-correlations with drug physicochemical properties and epithelial permeabilityJ Drug Target2003111617412852442
  • GeiserMGerberPMayeIIm HofVGehrPRetention of Teflon particles in hamster lungs: a stereological studyJ Aerosol Med2000131435510947323
  • JohnJWollmerPDahlbackMLutsAJonsonBTidal volume and alveolar clearance of insoluble particlesJ Appl Physiol19947625845888175567
  • LayJCStangMRFisherPEYankaskasJRBennettWDAirway retention of materials of different solubility following local intrabronchial deposition in dogsJ Aerosol Med200316215316612823909
  • JacobsCMüllerRHProduction and characterization of a budesonide nanosuspension for pulmonary administrationPharm Res200219218919411883646
  • CerasoliFJrDeveloping the ideal inhaled corticosteroidChest20061301 Suppl54S64S16840368